Trials Sponsors Conditions Drugs Pricing

Conditions

Oroantral Fistula

Outcome Measures

Primary Outcomes (1)

Evaluation of the soft tissue wound's healing
closure of the fistula using the Clinical Healing Score (CHS). CHS: score ranging from 0-5
1st, 7th, and14 days postoperatively

Secondary Outcomes (1)

Secondary radiographic outcomes, assessment of bone formation
24 weeks postoperatively

Study Arms (1)

closure of the OAF with PRF application

EXPERIMENTAL

This study was conducted on 9 patients. application of PRF membrane

Procedure: closure by PRF membrane

Interventions

closure by PRF membraneProcedure

Oral fistulectomy was done with proper curettage. EMMA was performed. closure of the OAF by application of PRF membrane and covering it with an acrylic splint

closure of the OAF with PRF application

Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.

Eligibility Criteria

Age20 Years - 60 Years

Sexall

Healthy VolunteersYes

Age GroupsAdult (18-64)

You may qualify if:

Adult patients between the ages of 20-60 years. 2- Patients who were suffering from chronic fistula that occurred after the extraction of upper posterior teeth

You may not qualify if:

Sponsors & Collaborators

Alexandria University
Otherlead

Study Sites (1)

Faculty of Dentistry

Alexandria, 562589, Egypt

Related Publications (1)

Elgabarty AT, Elmahallawy AS, Ibraheam AA, Oraby MS. Closure of oroantral fistula using platelet rich fibrin with endoscopic middle meatal antrostomy. BMC Oral Health. 2024 Jun 16;24(1):698. doi: 10.1186/s12903-024-04409-0.
PMID: 38880902DERIVED

MeSH Terms

Conditions

Oroantral Fistula

Condition Hierarchy (Ancestors)

Oral FistulaMouth DiseasesStomatognathic DiseasesFistulaPathological Conditions, AnatomicalPathological Conditions, Signs and Symptoms

Study Officials

MONA SAMY, PHD
Alexandria University
STUDY DIRECTOR

Enrollment

9 participants (actual enrollment reported by the registry).

Study Design

Study Type: interventional
Phase: not applicable
Allocation: NA
Masking: NONE
Purpose: TREATMENT
Intervention Model: SINGLE GROUP
Sponsor Type: OTHER
Responsible Party: SPONSOR

Study Record Dates

First Submitted

February 12, 2024

First Posted

February 28, 2024

Study Start

March 27, 2023

Actual (reported)

Closure of Oroantral Fistula (OAF) Using Platelet Rich Fibrin With Middle Meatal Antrostomy

Brief Summary

Registry Overview

Trial Relationships

Study Timeline

Study Start

Primary Completion

Study Completion

First Submitted

First Posted

Conditions

Outcome Measures

Primary Outcomes (1)

Secondary Outcomes (1)

Study Arms (1)

closure of the OAF with PRF application

Interventions

Eligibility Criteria

You may qualify if:

You may not qualify if:

Sponsors & Collaborators

Study Sites (1)

Related Publications (1)

MeSH Terms

Conditions

Condition Hierarchy (Ancestors)

Study Officials

Enrollment

Study Design

Study Record Dates

Data Sharing

Source record

Locations

Brief Summary

Registry Overview

Trial Relationships

Related Scientific Literature

Study Timeline

Study Start

Primary Completion

Study Completion

First Submitted

First Posted

Conditions

Outcome Measures

Primary Outcomes (1)

Secondary Outcomes (1)

Study Arms (1)

closure of the OAF with PRF application

Interventions

Eligibility Criteria

You may qualify if:

You may not qualify if:

Sponsors & Collaborators

Study Sites (1)

Related Publications (1)

MeSH Terms

Conditions

Condition Hierarchy (Ancestors)

Study Officials

Enrollment

Study Design

Study Record Dates

Data Sharing

Source record

Locations